Axonics, Inc.
NASDAQ Global SelectTotal Valuation
Axonics, Inc. carries a market capitalization of 3.63B, placing it among publicly traded companies globally. Its enterprise value stands at 3.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.63B |
| Enterprise Value | 3.19B |
Share Statistics
Axonics, Inc. currently has 51.11M shares outstanding.
| Shares Outstanding | 51.11M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 8.11, and the price-to-book ratio stands at -8.93.
| PE Ratio | N/A |
| PS Ratio | 8.11 |
| PB Ratio | -8.93 |
| P/TBV Ratio | 7.28 |
| P/FCF Ratio | 153.04 |
| P/OCF Ratio | 245.20 |
Enterprise Valuation
On an enterprise value basis, Axonics, Inc. trades at an EV/EBITDA multiple of 605.38 and an EV/FCF ratio of 136.50.
| EV / Sales | 7.39 |
| EV / EBITDA | 605.38 |
| EV / EBIT | N/A |
| EV / FCF | 136.50 |
Financial Position
Axonics, Inc. maintains a current ratio of 8.16, meaning it holds 8.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.89, indicating elevated leverage, while an interest coverage ratio of 57.95 demonstrates strong ability to service its debt obligations.
| Current Ratio | 8.16 |
| Quick Ratio | 6.33 |
| Debt / Equity | 4.89 |
| Debt / EBITDA | 6.17 |
| Interest Coverage | 57.95 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -0.79 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 0.40 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.07 |
Taxes
Over the trailing twelve months, Axonics, Inc. has paid 2.65M in income taxes, reflecting an effective tax rate of 17.39.
| Income Tax | 2.65M |
| Effective Tax Rate | 17.39 |
Stock Price Statistics
Axonics, Inc.'s stock has gained approximately 19.25403% over the past 52 weeks. The 50-day moving average sits at - -, while the 200-day moving average is - -.
| Beta (5Y) | N/A |
| 52-Week Price Change | 19.25403% |
| 50-Day Moving Average | - - |
| 200-Day Moving Average | - - |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Axonics, Inc. generated 431.90M in revenue and converted that into -5.66M in net income, yielding earnings per share of -0.11. EBITDA reached 5.27M, while operating income came in at -7.22M.
| Revenue | 431.90M |
| Gross Profit | 330.81M |
| Operating Income | -7.22M |
| Pretax Income | -3.01M |
| Net Income | -5.66M |
| EBITDA | 5.27M |
| EBIT | -7.22M |
| Earnings Per Share (EPS) | -0.11 |
Balance Sheet
Axonics, Inc. holds 345.23M in cash and equivalents against 32.51M in total debt, resulting in a net debt position of -239.45M. Total book value stands at -392.58M, with working capital of 461.50M providing operational flexibility.
| Cash & Cash Equivalents | 345.23M |
| Total Debt | 32.51M |
| Net Debt | -239.45M |
| Equity (Book Value) | -392.58M |
| Book Value Per Share | -7.80 |
| Working Capital | 461.50M |
Cash Flow
Axonics, Inc. produced 14.29M in operating cash flow over the past twelve months. After subtracting -8.92M in capital expenditures, free cash flow totaled 5.37M - equivalent to 0.11 per share.
| Operating Cash Flow | 14.29M |
| Capital Expenditures | -8.92M |
| Free Cash Flow | 5.37M |
| FCF Per Share | 0.11 |
Margins
Axonics, Inc. operates with a gross margin of 76.59, reflecting its pricing power and cost economics. The operating margin of -1.67 and net profit margin of -1.31 provide insight into operational efficiency.
| Gross Margin | 76.59 |
| Operating Margin | -1.67 |
| Pretax Margin | -0.70 |
| Profit Margin | -1.31 |
| EBITDA Margin | 1.22 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.10 |
| FCF Yield | 0.65 |
Scores
Axonics, Inc. posts an Altman Z-Score of 19.87, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 19.87 |